Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy

Lancet

Volumn 357, Issue 9249, 2001, Pages 39-40

  Liu, Hongxiang ^a   Ruskon Fourmestraux, Agnes ^b,c   Lavergne Slove, Anne ^b,c   Ye, Hongtao ^a   Molina, Thierry ^b,c   Bouhnik, Yoram ^b   Hamoudi, Rifat A ^d   Diss, Tim C ^a   Dogan, Ahmet ^a   Megraud, Francis ^c,e   Rambaud, Jean Claude ^b,c   Du, Ming Qing ^a   Isaacson, Peter G ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c GELD (Groupe d'Etude des Lymphomes Digestifs)   (France)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e Laboratoire de Bactériologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHIMERA; CHROMOSOME 18; CHROMOSOME TRANSLOCATION 11; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; ERADICATION THERAPY; FEMALE; FOLLOW UP; FUSION GENE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035814637     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03571-6     Document Type: Article

References (5)

1. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
2. Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: Results of an ongoing multicenter trial
3. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas
4. Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection
5. BCL10 mutation in lymphoma